Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
about
Interferon lambda: a new sword in cancer immunotherapyA new insight into hepatitis C vaccine developmentIFNL3 mRNA structure is remodeled by a functional non-coding polymorphism associated with hepatitis C virus clearanceVaccination for hepatitis C virus: closing in on an evasive targetA variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virusAlpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infectionHepatitis C virus protease inhibitor-resistance mutations: our experience and reviewAn update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver DiseasesHepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphismsCellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?KASL clinical practice guidelines: management of hepatitis CRecent advances in understanding hepatitis CNatural killer cells in hepatitis C: Current progressGenetic background in nonalcoholic fatty liver disease: A comprehensive reviewNK cell function and receptor diversity in the context of HCV infectionInterferon-λ: Immune Functions at Barrier Surfaces and BeyondImpact of IL28B, ITPA and PNPLA3 genetic variants on therapeutic outcome and progression of hepatitis C virus infectionNatural history and clinical response: "it's the virus, stupid, or is it the host?"The chemokine superfamily revisitedRegulation of hepatic innate immunity by hepatitis C virusPersonalized medicine and human genetic diversityInborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypesFactors associated with the response to interferon-based antiviral therapies for chronic hepatitis CA conceptual framework for pharmacodynamic genome-wide association studies in pharmacogenomicsPopulation genetics and human immunity: the interferon paradigmNatural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experienceAntiviral treatment of hepatitis C virus infection and factors affecting efficacyHepatitis C virus adaptation to T-cell immune pressureSystematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?Immune responses to HCV and other hepatitis virusesMurine models of hepatitis C: what can we look forward to?Population genetic tools for dissecting innate immunity in humansT cell responses in hepatitis C virus infection: historical overview and goals for future researchInduction and function of type I and III interferon in response to viral infectionPost-transcriptional regulation of interferons and their signaling pathwaysGenetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactionsTargeted induction of interferon-λ in humanized chimeric mouse liver abrogates hepatotropic virus infectionContribution of Genome-Wide HCV Genetic Differences to Outcome of Interferon-Based Therapy in Caucasian American and African American PatientsGenomic scale analysis of racial impact on response to IFN-alphaCrystal Structure of Human Interferon-λ1 in Complex with Its High-Affinity Receptor Interferon-λR1
P2860
Q21296797-2B40B291-38C9-4AD9-928C-2814FFB2A669Q21296858-C1D405E5-EA3E-4D62-9311-FA1753650710Q22121973-919A06F1-7C95-4584-A811-6428856A1524Q22305922-5E272207-B46F-48F1-B005-A548DFAD89F6Q24307721-9F61F10A-B56D-4180-BB01-218B4C1B850FQ24611884-BFFC4B44-F282-4553-8050-7837C89073F6Q24628717-F3049E39-69FC-48F1-9E62-D92C1EF98B5CQ24632766-4F36FFAD-8B9B-4B8E-8CD1-8C99D8E10171Q26738545-3C8DF90C-8788-4AB2-B6FC-03F5CBB6F6AAQ26749249-0C33452F-2A24-4947-81FC-7668F5A619B5Q26752471-E9D2E642-6D11-4346-8329-ADAF5EB17377Q26766136-4C204373-0E65-4494-916D-40EB24FA0B11Q26773264-BBB3E52D-26A6-4880-90CF-1C3D09563B34Q26780248-CF637DCD-29BA-4399-B00A-3FCA90E0BADAQ26781537-1A0645F9-4A68-449E-B3A4-F35774C68267Q26801049-8F8E7A35-142F-447C-B714-B7DDB8BC153BQ26801381-D90B6EC2-E369-4865-92E5-54EB22398922Q26824094-071DA391-18AE-4F78-B1FF-751C8E7936A6Q26824492-BBE8F7A2-AD72-427C-AC07-7C08D1376A5AQ26824743-CE9736FA-852A-49AB-9278-97EC6109ADB7Q26824838-021B5BBA-8F23-4DAD-8080-90EE79F6C973Q26825342-E186A7C1-2FE0-476A-8541-D0EB29AEB378Q26825715-223AC56C-C2D9-434D-9102-5ABBEB01DF3EQ26827814-FD63F9BF-A31A-4EF7-A6B8-D0DE719C4852Q26830286-C844E522-6576-43E4-844B-1632B5907E30Q26850968-D647B04C-1153-41CD-9FF4-7CA622B5B59BQ26851810-CE339227-64A9-4394-922F-EF5C43AD495FQ26862729-86E8BCDB-7782-4EA5-817B-C97218B691C3Q26865747-86CF80BA-48F7-4178-88EE-F4201D547D5DQ26866955-F8D2BAB6-92DD-4168-92E0-57E500E219CDQ26991875-66A2AB9E-A326-42B9-9B7F-6ECD8BF91515Q27001032-8FC370C6-2D2A-48EF-833A-CEAE2E534090Q27003510-AEC8E1DA-EEB1-489A-93F7-707652342234Q27010065-BD1927F3-4748-4090-860B-C6272445C275Q27014043-64D3B948-82F4-4140-A960-40E867D725A8Q27014831-0704A469-C24D-4FFC-BA1B-C21CCE111DC6Q27333253-E3BD8625-4A86-44C4-9796-A0874F0AF24CQ27490885-F3F3AD17-F904-42C5-94D6-2E9EF260248CQ27490906-BF969F90-7010-4639-A63D-45BA1FFDD55EQ27664960-27174F19-F18F-4648-8C6A-0965F3A04565
P2860
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
description
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
articolo scientifico
@it
artículu científicu espublizáu en 2009
@ast
im Oktober 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: October 2009)
@en
wetenschappelijk artikel (gepubliceerd in 2009-10)
@nl
наукова стаття, опублікована в жовтні 2009
@uk
مقالة علمية (نشرت في أكتوبر 2009)
@ar
name
Genome-wide association of IL2 ...... herapy for chronic hepatitis C
@ast
Genome-wide association of IL2 ...... herapy for chronic hepatitis C
@en
type
label
Genome-wide association of IL2 ...... herapy for chronic hepatitis C
@ast
Genome-wide association of IL2 ...... herapy for chronic hepatitis C
@en
prefLabel
Genome-wide association of IL2 ...... herapy for chronic hepatitis C
@ast
Genome-wide association of IL2 ...... herapy for chronic hepatitis C
@en
P2093
P3181
P356
P1433
P1476
Genome-wide association of IL2 ...... herapy for chronic hepatitis C
@en
P2093
Korenaga M
P2888
P304
P3181
P356
10.1038/NG.449
P407
P577
2009-10-01T00:00:00Z
P5875
P6179
1049900143